Reverse Transcriptase News and Research

RSS

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

The advent of the B.1.1.529 (Omicron) severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) variant, detected initially in Botswana and South Africa and now found in over 135 countries as of January 3, 2022, has sparked fears of a new global wave of infections and hospitalizations

3 Jan 2022

Rapid antigen tests show lower sensitivity for Omicron than for earlier SARS-CoV-2 variants

Researchers carried out an analytical susceptibility test with cultured SARS-CoV-2 Omicron variant in seven antigen-detecting rapid diagnostic (Ag-RDTs).

29 Dec 2021

MRNA boosters shown to increase protection against SARS-CoV-2 Omicron

Researchers evaluate vaccine effectiveness against SARS-CoV-2 Omicron and Delta variants.

29 Dec 2021

Coinfection of SARS-CoV-2 and human rhinovirus associated with more severe health outcomes

Researchers discuss the incidence and effect of coinfections with SARS-CoV-2 and human rhinovirus.

23 Dec 2021

More breakthrough infections but less severe COVID-19 with Omicron

In a recent study posted to the bioRxiv* pre-print server, an international team of researchers reported the occurrence of coronavirus disease 2019 (COVID-19) breakthrough infections (BTIs) among health care workers (HCWs) participating in a phase III vaccine trial in Sisonke, South Africa.

22 Dec 2021

Comparison of SARS-CoV-2 rapid antigen tests

Researchers test commercially rapid antigen tests to evaluate their analytical sensitivity and specificity, as well as clinical sensitivity for detecting SARS-CoV-2.

21 Dec 2021

Comparison of point-of-care SARS-CoV-2 diagnostic kits

A multinational group of scientists investigates the performance characteristics of several point-of-care diagnostic kits for SARS-CoV-2.

21 Dec 2021

White-tailed deer are efficient carriers of SARS-CoV-2

Researchers demonstrate the susceptibility of white-tailed deer to SARS-CoV-2.

20 Dec 2021

Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in One-Step Assays for RNA Detection in PCR Testing, including COVID-19 Testing

Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the launch of its Codex® HiTemp Reverse Transcriptase for use in one-step quantitative reverse transcription PCR (RT-qPCR).

From Codexis 17 Dec 2021

Delta SARS-CoV-2 variant drove increase in infection numbers in the U.K.

Researchers determine how different the SARS-CoV-2 Delta variant was from the previously dominant Alpha variant.

7 Dec 2021

Colorimetric detection of SARS-CoV-2 viral RNA by an in vitro transcription/translation assay

This work has emphasized the clinical and translational potential of paper-based biosensors.

6 Dec 2021

Maternal morbidities and outcomes in pregnant women with COVID-19

Researchers aimed to determine whether maternal morbidities and adverse obstetrical outcomes were more frequent in pregnant women with COVID-19.

5 Dec 2021

CRISPR-based DETECTR® assay for faster SARS-CoV-2 surveillance

Researchers from the USA discuss the development and validation of CRISPR-Cas12-based COVID-19 variant DETECTR® assay for the detection of SARS-CoV-2.

3 Dec 2021

Risk of COVID-19 hospitalization among children with markers of uncontrolled asthma

The paper describes a national cohort study including all children in Scotland between the ages of 5 and 17 years who were part of the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II).

3 Dec 2021

New bioinformatics method for viral sgRNA analysis

A recent study discusses a bioinformatics method to help identify and explore sgRNAs uncovered in next-generation sequencing data.

2 Dec 2021

Study shows that nucleic acid amplification tests more accurate in detecting SARS-CoV-2 than rapid antigen

Researchers use reference preparations from pooled swab samples to compare the analytical sensitivity of different SARS-CoV-2 assays

30 Nov 2021

Prior infection with SARS-CoV-2 continues to provide protection from reinfection

Researchers from the University of Michigan investigated the correlation between SARS-CoV-2 infection and the severity of reinfections.

30 Nov 2021

Host and in vitro genomic variability of SARS-CoV-2 and its variants

Researchers from the University of Sydney investigate the genomic variability of SARS-CoV-2 within the host and in vitro.

30 Nov 2021

How often does SARS-CoV-2 infect alongside another viruses?

Researchers have been exploring data from COVID-19 patients tested at hospitals or clinics that also look for evidence of other diseases.

28 Nov 2021

The introduction and rapid spread of SARS-CoV-2 Gamma in Venezuela

Researchers from the Instituto Venezolano de Investigaciones Científica investigate the introduction of one of the VOCs into Venezuela.

28 Nov 2021

Reverse Transcriptase News and Research

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

Rapid antigen tests show lower sensitivity for Omicron than for earlier SARS-CoV-2 variants

MRNA boosters shown to increase protection against SARS-CoV-2 Omicron

Coinfection of SARS-CoV-2 and human rhinovirus associated with more severe health outcomes

More breakthrough infections but less severe COVID-19 with Omicron

Comparison of SARS-CoV-2 rapid antigen tests

Comparison of point-of-care SARS-CoV-2 diagnostic kits

White-tailed deer are efficient carriers of SARS-CoV-2

Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in One-Step Assays for RNA Detection in PCR Testing, including COVID-19 Testing

Delta SARS-CoV-2 variant drove increase in infection numbers in the U.K.

Colorimetric detection of SARS-CoV-2 viral RNA by an in vitro transcription/translation assay

Maternal morbidities and outcomes in pregnant women with COVID-19

CRISPR-based DETECTR® assay for faster SARS-CoV-2 surveillance

Risk of COVID-19 hospitalization among children with markers of uncontrolled asthma

New bioinformatics method for viral sgRNA analysis

Study shows that nucleic acid amplification tests more accurate in detecting SARS-CoV-2 than rapid antigen

Prior infection with SARS-CoV-2 continues to provide protection from reinfection

Host and in vitro genomic variability of SARS-CoV-2 and its variants

How often does SARS-CoV-2 infect alongside another viruses?

The introduction and rapid spread of SARS-CoV-2 Gamma in Venezuela

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News